67°
Feels Like: 67°
75°
57°
58°
(Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main ...
Read More »
By Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former bio...
Read More »
By Kate Kelland, Health and Science Correspondent LONDON (Reuters) - For a pathogen with such a short history, the mysterious new vi...
Read More »
(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by...
Read More »
By Ben Hirschler LONDON (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with Gla...
Read More »
By Alex Dobuzinskis LOS ANGELES (Reuters) - Voters strongly supported a ballot measure to sharply curtail the number of medical mari...
Read More »By Ben Hirschler LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the...
Read More »
(Reuters) - Merck & Co Inc said it has entered into a $5 billion share repurchase agreement with Goldman Sachs Group Inc, as the dru...
Read More »(Reuters) - Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch o...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Young adult drivers who usually get less than six hours of sleep per night are more ...
Read More »
